The American Journal of Medicine
Volume 122, Issue 12 , Pages 1122-1127, December 2009

Obstructive Sleep Apnea as a Risk Factor for Type 2 Diabetes

  • Nader Botros, MD, MPH

      Affiliations

    • Division of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of Medicine, New Haven, Conn
  • ,
  • John Concato, MD

      Affiliations

    • Division of General Internal Medicine, Yale University School of Medicine, New Haven, Conn
    • Clinical Epidemiology Research Center (CERC), Veterans Affairs Connecticut Healthcare System, West Haven
  • ,
  • Vahid Mohsenin, MD

      Affiliations

    • Division of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of Medicine, New Haven, Conn
  • ,
  • Bernardo Selim, MD

      Affiliations

    • Division of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of Medicine, New Haven, Conn
  • ,
  • Kervin Doctor, MD

      Affiliations

    • Clinical Epidemiology Research Center (CERC), Veterans Affairs Connecticut Healthcare System, West Haven
  • ,
  • Henry Klar Yaggi, MD, MPH

      Affiliations

    • Division of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of Medicine, New Haven, Conn
    • Clinical Epidemiology Research Center (CERC), Veterans Affairs Connecticut Healthcare System, West Haven
    • Corresponding Author InformationRequests for reprints should be addressed to Henry Klar Yaggi, MD, MPH, Department of Internal Medicine, Yale University School of Medicine, 300 Cedar St., TAC 441s, P.O. Box 208057, New Haven, CT 06520

Abstract 

Purpose

Cross-sectional studies have documented the co-occurrence of obstructive sleep apnea (hereafter, sleep apnea) with glucose intolerance, insulin resistance, and type 2 diabetes mellitus (hereafter, diabetes). It has not been determined, however, whether sleep apnea is independently associated with the subsequent development of diabetes, accounting for established risk factors.

Methods

This observational cohort study examined 1233 consecutive patients in the Veteran Affairs Connecticut Healthcare System referred for evaluation of sleep-disordered breathing; 544 study participants were free of preexisting diabetes and completed a full, attended, diagnostic polysomnogram. The study population was divided into quartiles based on severity of sleep apnea as measured by the apnea-hypopnea index. The main outcome was incident diabetes defined as fasting glucose level >126 mg/dL and a corresponding physician diagnosis. Compliance with positive airway pressure therapy, and its impact on the main outcome, also was examined.

Results

In unadjusted analysis, increasing severity of sleep apnea was associated with an increased risk of diabetes (P for linear trend <.001). After adjusting for age, sex, race, baseline fasting blood glucose, body mass index, and weight change, an independent association was found between sleep apnea and incident diabetes (hazard ratio per quartile 1.43; confidence interval 1.10-1.86). Among patients with more severe sleep apnea (upper 2 quartiles of severity), 60% had evidence of regular positive airway pressure use, and this treatment was associated with an attenuation of the risk of diabetes (log-rank test P=.04).

Conclusion

Sleep apnea increases the risk of developing diabetes, independent of other risk factors. Among patients with more severe sleep apnea, regular positive airway pressure use may attenuate this risk.

Keywords: Sleep apnea syndrome, Type 2 diabetes mellitus

 

 Funding: VA Health Services Research and Development/Clinical Science, Career Development Awards to Dr. Yaggi. National Research Service Award Institutional Research Training Grant (5T32HL07778) to Dr. Botros.

 Conflict of Interest: The authors have no relevant conflicts of interest to disclose.

 Authorship: All authors had access to the data and a role in writing the manuscript.

PII: S0002-9343(09)00679-2

doi:10.1016/j.amjmed.2009.04.026

The American Journal of Medicine
Volume 122, Issue 12 , Pages 1122-1127, December 2009